Clinical trial performance

Annual changes per types of clinical trials conducted

Trial	2021		2022		2023		2024		2025		合計
Trial	Trial	Number of cases	Trial	Number of cases	Trial	Number of cases	Trial	Number of cases	Trial	Number of cases	Trial	Number of cases
Phase I trial (Including female, elderly, and caucasian)	3	48	3	66	1	48	2	56	3	80	12	298
Patient-targeted clinical examination (Including Ph I trial)	1	10	1	4	1	11					3	25
Original drug BE/PK test Other PK test（DDI, FE, etc.）	2	66	2	102	2	98	2	58			8	324
Vaccine test (Including children and elderly)	2	168	2	59			1	36			5	263
Phase II trial											0	0
Generic BE/PK test (Healthy male, female, postmenopausal female)	5	192	5	160	5	120	9	275	8	192	32	939
Others									1	200	1	200
Total	13	484	13	391	9	277	14	425	12	472	61	2049

Since 2014, we have started accepting orders for clinical pharmacology trials targeting patients. Currently, renal impairment patients (mild, moderate, severe, dialysis): 7 trials /Anemia patients: 1 trial /T2DM: 1 trial /SAS: 2 trials /ALS: 1 trial /PD comparison (BE) examinations for glaucoma patients: 2 trials / Totaling 14 trials, with a total of more than 200 cases.

In addition to our own volunteer panels, it is possible to accumulate subjects by making use of our favorable location and cooperation with many PROs (Patient Recruitment Organizations). In addition, we are able to conduct a wide variety of clinical trials through collaboration with the neighboring Sekino Hospital in the same group.